Follow us
Latest News & Events
Project Launch Ceremony – KFBIO partners with the Second Afflicted Hospital Zhejiang University School of Medi
On February 12, 2022, the signing ceremony of KFBIO and the Second Afflicted Hospital Zhejiang University School of Medicine was held successfully. It witnessed the partnership of two sides to officially launch the project of AI-assisted pathology slides production. Wang Haijun, the pathology department deputy director of Second Afflicted Hospital Zhejiang University School of Medicine, Liu Bingxian, the chairman and general manager of KFBIO and other representatives attended this ceremony.
Highlights
At the project launch ceremony, Director Wang delivered a speech first, followed by General Manager Mr. Liu. Director Wang said that the excellent quality of pathology slides is the basis of pathology diagnosis. However, the quality of pathology slides is uneven due to the complex process of pathology slides production, low degree of automation and the lack of pathology technicians professional training. Manual quality control is time-consuming, inefficient and lacks unified standards. It’s difficult to carry out refined quality control under the condition that department staff is busy with daily work. So it’s urgent to use information technology and artificial intelligence tools to realize refined quality control of pathology slides production and standardize the workflow.
General Manager Mr. Liu expressed the appreciation to the Second Afflicted Hospital Zhejiang University School of Medicine for its great support and recognition of KFBIO. KFBIO has always been devoted to promoting the standardization of pathology slides production. We look forward to producing more industry results under the cooperation of both sides to promote the development of pathology departments and contribute to constructing the standardized pathology laboratory.
Gui Kun, the deputy general manager of KFBIO, reported the project cooperation results of the AI-assisted pathology slides production quality analysis and evaluation system. Two sides discussed the industry status, project cooperation plans and expected results to jointly promote the innovation and development of pathology industry.

Pathology slides quality analysis and evaluation are the key elements for diagnosis. KFBIO develops the pathology information management system independently to realize the whole workflow track of samples. Based on the data of whole workflow sample track, AI makes it easy to realize the quality control of slide production and automatic export quality report to realize the management of pathology department.
After deep discussion several times, two sides have reached a strategic cooperation agreement in the project of the AI-assisted pathology slides production quality analysis and evaluation. KFBIO will make full use of its own research and development strengths to provide optimal digital pathology solutions together with experts.

Relying on the digital pathology imaging system, KFBIO has established an open AI analysis platform that is compatible with mainstream AI analysis software. It integrates the advantages of different high-quality AI analysis modules to form a pathology image artificial intelligence analysis platform suitable for clinical and scientific research, covering the slide production quality control and diagnostic quality control.

